Page 121 - Reuters%20/t%20_blank%20

Adani group's settlement pleas delayed by Sebi's review of processes

The review could take three months after which the Adani pleas will be taken up under new processes, said the second source, with direct knowledge of the matter

Gold rally to dent India's jewellery purchases, boost investment: WGC

Domestic gold prices hit a record high of ₹99,358 per 10 grams earlier this month

ArcelorMittal warns of trade disruption despite strong quarterly profit

ArcelorMittal shipped about 13.6 million tons of steel in the first quarter, slightly up from the year-ago period

RBI has room for more rate cuts, but with caution, says rate panel member

Going forward, continuing policy easing - both rate cuts and liquidity infusions - could eventually alter the growth-inflation

Starbucks earnings disappoint as CEO Niccol's strategy hits US roadblocks

Investors have placed their bets on Niccol's turnaround strategy for the brand, whose sales have fallen for four straight quarters

China's factory activity shrinks in Apr as PMI dips to 49, recovery stalls

The official purchasing managers' index (PMI) fell to 49.0 in April versus 50.5 in March, below the 50-mark separating growth from contraction

Brics group shows internal rifts as ministers fall short of joint statement

Brazil said the group's foreign ministers expressed "serious concern at the prospect of a fragmented global economy and the weakening of multilateralism"

UPS to cut 20,000 jobs on lower Amazon shipments; profit beats estimates

The company last year said it cut its workforce by 12,000 jobs. It expects expenses between $400 million to $600 million during 2025

US goods trade deficit widens in March due to sharp jump in imports

Goods imports soared $16.3 billion to $342.7 billion, likely as businesses rushed to bring in goods to avoid President Donald Trump's sweeping tariffs

Wall Street choppy as markets juggle trade war news, mixed earnings

The world's two largest economies have slapped tit-for-tat import tariffs on each other and uncertainty around the state of negotiations between the two has kept markets on edge

Amazon denies plans to display Donald Trump-imposed tariffs on listings

Trump has imposed a tsunami of tariffs on US trading partners, including China, which has seen tariff costs rise by 145 per cent since Trump took office

World Bank forecasts commodity prices to fall to pre-covid levels by 2026

The World Bank report also forecast that gold prices are likely to set a new record in 2025 as investors seek safe havens for capital amid rising uncertainty, but the price will stabilize in 2026

AO Smith Q1 revenue dips 2% on weak US, China water heater demand

The company, which makes residential and commercial water heaters, boilers, tanks and treatment products, posted a 2 per cent fall in quarterly sales to $963.9 million

S&P Global to separate its mobility division from parent to streamline biz

S&P Global's first-quarter profit beat analysts' expectations, as demand for its data and analytics offerings remained robust amid economic turmoil

PayPal maintains annual revenue, profit estimates amid US trade uncertainty

The company's results show that consumers are continuing to spend despite worries that Trump's trade war could lead to a recession

India may offer future-proof trade sweetener to fast-track US deal: Report

India has already made a number of offers and pre-emptive concessions to the US on trade, showing itself more eager than several other big US trading partners

AstraZeneca says potential US tariffs manageable; faces another China fine

"If tariffs were implemented in the range we have seen recently in other industries on medicines imported from Europe to the U.S., we would remain within the guidance range we indicated for 2025,"

Spotify Q2 profit forecast misses estimates as payroll taxes weigh down

It expects monthly active users to rise to 689 million in the second quarter, compared with LSEG-compiled estimates of 684.9 million. Premium subscribers are expected to increase to 273 million

Pfizer beats Q1 profit estimates on cost cut, strong sale of heart drug

It reported total revenue of $13.70 billion for the first quarter, compared with analysts' expectations of $13.91 billion, according to LSEG data

Merck to invest $1 bn in new Delaware plant to boost US manufacturing

The company expects labs at the new facility to be fully operational by 2028 and produce experimental drugs by 2030